Naive circulating B cells with moderate PD-L1 expression isolated from patients with stage III and stage IV melanoma, could significantly suppress pro-inflammatory T cell responses in a PD-L1-dependent mechanism [25, 116]. Here, CD274 is linked to melanoma.